18 May 2013
Keywords: alnylam, amends, deal, merck, co, rnai, therapeutics
Article | 17 July 2006
RNAi therapeutics specialist Alnylam Pharmaceuticals has amended its two existing collaboration agreements with fellow USA-based Merck & Co into
a single ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 2006
17 May 2013
© 2013 thepharmaletter.com